Reaction
Pneumococcal Infection reporting signals
As of the last recalculation, Pneumococcal Infection appears in 579 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is BISACODYL SUPPOSITORIES (PRR 69.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bisacodyl Suppositories | 24 | 69.5 | 69.6 |
| Biscodyl | 24 | 68.9 | 69.0 |
| Bisacodyl | 24 | 63.9 | 64.0 |
| Standardized Senna Concentrate | 20 | 59.1 | 59.2 |
| Cortisone Acetate | 18 | 54.1 | 54.1 |
| Pramipexole | 22 | 53.6 | 53.7 |
| Ceftriaxone | 40 | 47.0 | 47.1 |
| Ceftriaxone Sodium | 46 | 46.8 | 46.8 |
| Erythromycin | 23 | 45.9 | 45.9 |
| Mometasone | 22 | 44.8 | 44.8 |
| Senna Leaf | 19 | 30.6 | 30.6 |
| Thiotepa | 7 | 26.7 | 26.7 |
| Quetiapine Fumarate | 21 | 26.5 | 26.5 |
| Trazodone Hydrochloride | 11 | 25.8 | 25.8 |
| Lopinavir And Ritonavir | 9 | 24.2 | 24.2 |
| Mepolizumab | 29 | 22.0 | 22.0 |
| Dexlansoprazole | 23 | 20.6 | 20.6 |
| Remdesivir | 7 | 19.1 | 19.1 |
| Bendamustine Hydrochloride | 5 | 15.1 | 15.1 |
| Palivizumab | 6 | 14.2 | 14.2 |
| Ranitidine Hydrochloride | 20 | 13.7 | 13.7 |
| Ravulizumab | 5 | 13.4 | 13.4 |